Abonnement à la biblothèque: Guest
Portail numérique Bibliothèque numérique eBooks Revues Références et comptes rendus Collections
Critical Reviews™ in Biomedical Engineering
SJR: 0.26 SNIP: 0.375 CiteScore™: 1.4

ISSN Imprimer: 0278-940X
ISSN En ligne: 1943-619X

Volumes:
Volume 48, 2020 Volume 47, 2019 Volume 46, 2018 Volume 45, 2017 Volume 44, 2016 Volume 43, 2015 Volume 42, 2014 Volume 41, 2013 Volume 40, 2012 Volume 39, 2011 Volume 38, 2010 Volume 37, 2009 Volume 36, 2008 Volume 35, 2007 Volume 34, 2006 Volume 33, 2005 Volume 32, 2004 Volume 31, 2003 Volume 30, 2002 Volume 29, 2001 Volume 28, 2000 Volume 27, 1999 Volume 26, 1998 Volume 25, 1997 Volume 24, 1996 Volume 23, 1995

Critical Reviews™ in Biomedical Engineering

DOI: 10.1615/CritRevBiomedEng.v37.i4-5.30
pages 355-375

Retinal Pigment Epithelium Differentiation of Stem Cells: Current Status and Challenges

Basak E. Uygun
Center For Engineering in Medicine, Shriners Hospital for Children, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA
Nripen Sharma
Epigeneres
Martin Yarmush
Center For Engineering in Medicine, Shriners Hospital for Children, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts; and Department of Biomedical Engineering, Rutgers University, Piscataway, NJ, USA

RÉSUMÉ

Degeneration and loss of retinal pigment epithelium (RPE) is the cause of a number of degenerative retinal diseases, including age-related macular degeneration (AMD), retinitis pigmentosa, and diabetic retinopathy, leading to blindness that affects three million Americans as of now. Transplantation of RPE aims to restore retinal structure and the interaction between the RPE and photoreceptors, which is fundamental to sight. Although a significant amount of progress has been made in the past 20 years in autologous RPE transplantation, sources for RPE cells are limited. Recent advances in stem cell culture and differentiation techniques have allowed the generation of RPE cells from pluripotent stem cells. In this review, we discuss strategies for generating functional RPE cells from human embryonic stem cells and induced pluripotent stem cells, and summarize transplantation studies of these derived RPEs. We conclude with challenges in cell-replacement therapies using human embryonic and induced pluripotent stem cell-derived RPEs.


Articles with similar content:

Potential Role of Induced Pluripotent Stem Cells as Regenerative Medicine in Retinal Cell Damage
Journal of Environmental Pathology, Toxicology and Oncology, Vol.37, 2018, issue 4
Yi-Ran Pan, Ying-Jian Sun, Bin Fan, Guang-Yu Li
Contribution of Neural Stem Cells to Regeneration of the Central Nervous System
International Journal of Physiology and Pathophysiology, Vol.5, 2014, issue 1
Tetyana A. Pivneva, Oksana A. Rybachuk
Converging Ideological Currents in the Adult Stem Cell Marketing Phenomenon
Ethics in Biology, Engineering and Medicine: An International Journal, Vol.3, 2012, issue 4
Douglas Sipp
Embryonic and Induced Pluripotent Stem Cells as a Model for Liver Disease
Critical Reviews™ in Biomedical Engineering, Vol.37, 2009, issue 4-5
Alejandro Soto-Gutierrez, Masaki Nagaya, Hiroshi Yagi, Ira J. Fox, Edgar Tafaleng, Stephen C. Strom, Marc C. Hansel
Yin Yang 1 (YY1): Regulation of Survivin and Its Role In Invasion and Metastasis
Critical Reviews™ in Oncogenesis, Vol.22, 2017, issue 1-2
Nicholas R. Galloway, Kathryn F. Ball, Nathan R. Wall, TessaRae Stiff